Enhanced Recovery after Pelvic Organ Prolapse Surgery

The objective of this study was to review on the influence of enhanced rehabilitation in pelvic organ prolapse surgery outcomes, specifically focusing on length of hospital stay, hospital costs, pain, morbidity, and patient satisfaction. Following the PRISMA model and using PubMed as a source, eight articles pertaining to prolapse surgery and two articles concerning vaginal hysterectomies were selected, all published between 2014 and 2021. These studies revealed no significant difference in terms of operating time, intra- and post-operative complications, intra-operative blood loss and post-operative pain scores before and after the introduction of the ERAS program. Only one study noted a difference in readmission rates. There was, however, a noticeable decrease in intra-operative and post-operative intravenous intakes, opioid administration, length of stay, and overall hospital costs with the adoption of ERAS. Additionally, with ERAS, patients were able to mobilize more rapidly, and overall patient satisfaction significantly improved.

Automated summary

This study aimed to review the influence of enhanced rehabilitation on outcomes of pelvic organ prolapse surgery. The findings showed no significant difference in operating time, complications, blood loss, and pain scores before and after the adoption of the enhanced recovery after surgery (ERAS) program. However, there was a noticeable decrease in intravenous intakes, opioid administration, length of stay, and overall hospital costs with the adoption of ERAS. Patients were also able to mobilize more rapidly and reported higher satisfaction levels.